Atrial Fibrillation, Cardiovascular Diseases, Cerebrovascular Disorders, Heart Failure, Mild Cognitive Impairment
Conditions
Keywords
Cardiovascular epidemiology, Prospective, observational cohort study, Biomarkers, Cardio- and cerebrovascular imaging
Brief summary
Akershus Cardiac Examination (ACE) 1950 Study is a large, observational, prospective, longitudinal, population-based cohort study. The overall aim is to establish an extensive cardio- and cerebrovascular age cohort of elderly subjects for various longitudinal long-term follow-up studies of cardiovascular and cerebrovascular disease.
Detailed description
Design: The Akershus Cardiac Examination (ACE) 1950 Study is a population-based, prospective, cerebro- and cardiovascular age-cohort study of all men and women born in 1950 in Akershus County, Norway. Time schedule: Study inclusion and baseline examinations took place in the period September 2012 - May 2015. Current status: 10-year follow-up examinations of all participants are undertaken in 2023-2025, and sub-studies are ongoing.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Resident in Akershus County (as per October 2011, prior to study invitation) * Born in the year of 1950 * Ability to consent to participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes related to CVD and CV-associated conditions | Maximum 35 years |
Secondary
| Measure | Time frame |
|---|---|
| Specific CV endpoints; e.g. acute myocardial infarction, heart failure, atrial fibrillation, etc. | Maximum 35 years |
| Specific CV-associated conditions, including renal, cerebrovascular, pulmonary, etc. | Maximum 35 years |
| Specific clinical phenotypes; e.g. myocardial and arterial structure and function, lung function, etc. | Maximum 35 years |
Other
| Measure | Time frame |
|---|---|
| Impact of left atrial size and function measurements by echocardiography on stroke risk in an 62-65-year-old cohort | Within 35 years |
| Relation between cognitive function and sub-clinical CVD in a 62-65-year-old Norwegian population cohort | Maximum 35 years |
Countries
Norway